JHM Biopharmaceutical (Hangzhou) Co., Ltd. announced that it has signed an agreement to issue common shares for CNY 100 million on May 7, 2024. The transaction will include participation from returning investor Tonghua Dongbao Pharmaceutical Co., Ltd. for 8.6759 % in the company. The transaction has been approved by the board of directors of the company at the 6th Meeting of the 11th Board of Directors.

The transaction has been reviewed and approved by the company's board of directors and does not need to be submitted to the shareholders' meeting for review.